Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 39

Results: 7

Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis.
Published in:
Oncogene, 2009, v. 28, n. 39, p. 3442, doi. 10.1038/onc.2009.212
By:
- Li, Y.;
- Ye, X.;
- Tan, C.;
- Hongo, J.-A.;
- Zha, J.;
- Liu, J.;
- Kallop, D.;
- Ludlam, M. J. C.;
- Pei, L.
Publication type:
Article
Rb2/p130 is the dominating pocket protein in the p53–p21 DNA damage response pathway leading to senescence.
Published in:
Oncogene, 2009, v. 28, n. 39, p. 3456, doi. 10.1038/onc.2009.222
By:
- Helmbold, H.;
- Kömm, N.;
- Deppert, W.;
- Bohn, W.
Publication type:
Article
PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers.
Published in:
Oncogene, 2009, v. 28, n. 39, p. 3499, doi. 10.1038/onc.2009.191
By:
- Klanrit, P.;
- Taebunpakul, P.;
- Flinterman, M. B.;
- Odell, E. W.;
- Riaz, M. A.;
- Melino, G.;
- Salomoni, P.;
- Mymryk, J. S.;
- Gäken, J.;
- Farzaneh, F.;
- Tavassoli, M.
Publication type:
Article
The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.
Published in:
Oncogene, 2009, v. 28, n. 39, p. 3487, doi. 10.1038/onc.2009.205
By:
- Said, N.;
- Frierson, H. F.;
- Chernauskas, D.;
- Conaway, M.;
- Motamed, K.;
- Theodorescu, D.
Publication type:
Article
5q– myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.
Published in:
Oncogene, 2009, v. 28, n. 39, p. 3429, doi. 10.1038/onc.2009.207
By:
- Eisenmann, K. M.;
- Dykema, K. J.;
- Matheson, S. F.;
- Kent, N. F.;
- DeWard, A. D.;
- West, R. A.;
- Tibes, R.;
- Furge, K. A.;
- Alberts, A. S.
Publication type:
Article
Targeted inhibition of the Hedgehog pathway in established malignant glioma xenografts enhances survival.
Published in:
Oncogene, 2009, v. 28, n. 39, p. 3468, doi. 10.1038/onc.2009.208
By:
- Sarangi, A.;
- Valadez, J. G.;
- Rush, S.;
- Abel, T. W.;
- Thompson, R. C.;
- Cooper, M. K.
Publication type:
Article
Physical and functional interaction between polyoma virus middle T antigen and insulin and IGF-I receptors is required for oncogene activation and tumour initiation.
Published in:
Oncogene, 2009, v. 28, n. 39, p. 3477, doi. 10.1038/onc.2009.209
By:
- Novosyadlyy, R.;
- Vijayakumar, A.;
- Lann, D.;
- Fierz, Y.;
- Kurshan, N.;
- LeRoith, D.
Publication type:
Article

Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 39

Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis.

Rb2/p130 is the dominating pocket protein in the p53–p21 DNA damage response pathway leading to senescence.

PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers.

The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.

5q– myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.

Targeted inhibition of the Hedgehog pathway in established malignant glioma xenografts enhances survival.

Physical and functional interaction between polyoma virus middle T antigen and insulin and IGF-I receptors is required for oncogene activation and tumour initiation.